Why the study?
Myocardial fibrosis is a defining hallmark of CKD-associated cardiovascular disease driven by chronic inflammation and macrophage polarization within the CKD microenvironment. This review examined the molecular and cellular mechanisms linking macrophage polarization to CKD-associated myocardial fibrosis and evaluated therapeutic strategies targeting this process.
Population
CKD-associated myocardial fibrosis
Design
Review
Answers are grounded in this paper and cite their sources.
CKD cardiac fibrosis may involve macrophage polarization; leaves open whether immune-targeted therapies improve outcomes.
Chronic kidney disease (CKD) represents a significant global health challenge and a strong independent driver of cardiovascular morbidity and death. Myocardial fibrosis is a defining pathological hallmark of CKD-associated cardiovascular disease and is now widely viewed as an immune-driven process fueled by chronic inflammation. Macrophages, which are key immune regulatory cells in the heart, undergo phenotypic polarization within the CKD microenvironment. This process is orchestrated by systemic inflammation, metabolic dysfunction, uremic toxin accumulation, and mechanical and mineral-metabolic stress, ultimately promoting myocardial fibrogenesis. In this review, we examined the molecular and cellular mechanisms by which macrophage polarization contributes to CKD-associated myocardial fibrosis. First, we summarized the origins, classification, and polarization states of cardiac macrophages, highlighting emerging insights from single-cell sequencing and spatial transcriptomics that reveal their spatiotemporal heterogeneity; on this basis, we proposed the perivascular fibrotic niche as a spatially organized microenvironment that may support fibrogenesis. Then, we discussed how cytokine signaling, metabolic reprogramming including altered glycolysis, tricarboxylic acid cycle metabolism, and uremic toxin accumulation, together with immune-metabolic interactions, reshape macrophage phenotypes, leading to extracellular matrix remodeling and pathogenic crosstalk with cardiac fibroblasts and cardiomyocytes. We further evaluated current therapeutic strategies targeting macrophage polarization, emphasizing both their therapeutic potential and the challenges posed by macrophage heterogeneity, the context-dependent functions of M2-like macrophages, and the need for spatially and temporally precise intervention. Finally, we proposed an integrative working model centered on a self-amplifying metabolism–inflammation–fibrosis cycle, in which site-specific histone lactylation (in particular H4K12 lactylation) is hypothesized to link metabolic dysregulation to sustained pro-fibrotic macrophage activation. Our findings indicate the need for direct validation in the CKD heart is required. Collectively, this framework highlights macrophage polarization as a promising therapeutic target while underscoring the need to move beyond the conventional M1/M2 paradigm toward precision immunomodulatory strategies that target specific macrophage subsets, fibrotic niches, and disease stages.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: